Rick Matthews: Powerful Perspective from Erin and the NBCA Team
Rick Matthews, Senior Vascular Consultant at Argon Medical Devices, Inc., reposted from Erin VanDyke on LinkedIn:
”Powerful perspective from Erin and the NBCA team.
A VTE Center of Excellence isn’t a “badge” — it’s a culture: prevention, rapid diagnosis, coordinated treatment, follow-up, and community awareness.
The in-person site visit matters because it shows how the team actually works together when minutes count.”
Quoting Erin VanDyke‘s post:
”’Why do you do in-person site visits for COE designation?’
It’s a question I get asked often — and honestly, it’s one of my favorite parts of the process to talk about.
At National Blood Clot Alliance, we believe that achieving a Center of Excellence designation should reflect more than the strength of one service line. It should represent a hospital-wide commitment to improving every aspect of VTE prevention, diagnosis, treatment, follow-up, and community awareness.
That’s why the site visit matters so much. Being there in person allows us to see and feel the culture — how the team communicates, how barriers are approached, and how deeply VTE awareness is woven into the organization.
It gives us a chance to meet the people who make the work happen — from the physicians and APPs to the nurses, pharmacists, and administrators — and to have honest conversations about what’s working, what’s not, and where we can help.
The goal isn’t just to evaluate readiness for designation; it’s to partner in building something sustainable.
To use objective data to refine pathways, strengthen careflows, and ultimately deliver the best possible outcomes for patients.
Because for us, the COE designation isn’t a finish line — it’s the beginning of an ongoing collaboration to grow, evolve, and raise the bar for VTE care together.”
Stay updated with Hemostasis Today.
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia